Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Assessment of a Therapeutic Vaccine in Combination With PD-1 Knockout T Cells in the Treatment of Prostate Cancer

NCT03525652 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Guangdong Pharmaceutical University as lead sponsor.

NCT NCT03525652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03525652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Assessment of a Therapeutic Vaccine in Combination With PD-1 Knockout T Cells in the Treatment of Prostate Cancer
Lead sponsor
The First Affiliated Hospital of Guangdong Pharmaceutical University
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 22, 2018
Completion date
August 30, 2021
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer